Zobrazeno 1 - 10
of 538
pro vyhledávání: '"C, Hawk"'
Autor:
Eudora Welty, Matthew C. Hawk
Publikováno v:
Eudora Welty Review. 15:7-16
Autor:
Matthew C. Hawk
Publikováno v:
Mississippi Quarterly. 74:161-178
Autor:
Sean Clees, Daniel H. Cha, Pujan Biswas, Vivek Boddapati, Séan J. Cassady, Christopher L. Strand, Ronald K. Hanson, Benjamin French, Alastair Gilmour, Kevin C. Hawk, Joseph M. Stitt, Xavier Ferlet
Publikováno v:
Proceedings of the Combustion Institute.
Publikováno v:
A24. HEART AND LUNGS: "BETTER TOGETHER".
Leachate treatment at municipal wastewater treatment facilities is one option for meeting water quality standards. One possible method to reduce cost and energy requirements is to treat the leachate on-site using artificially constructed wetlands. Th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e161fa0742fb67baf5c51387837ed664
https://doi.org/10.1201/9781003069850-23
https://doi.org/10.1201/9781003069850-23
Publikováno v:
AISTech2020 Proceedings of the Iron and Steel Technology Conference.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Tal Burt, D. K. Demasi, Malcolm Rowland, D. C. MacLeod, Mark N. Feinglos, K. Lee, Thomas C. Hawk, Antoinette Santoro, Robert J. Noveck
Publikováno v:
Clinical and Translational Science. 10:351-359
Intra-Target Microdosing (ITM) is a novel drug development approach aimed at increasing the efficiency of first-in-human (FIH) testing of new molecular entities (NMEs). ITM combines intra-target drug delivery and "microdosing," the subpharmacological
Autor:
Tal Burt, Huali Wu, Robert J. Noveck, Douglas C. Rouse, Kihak Lee, Thomas C. Hawk, Shein-Chung Chow, Anita T. Layton, Bennett B. Chin, Douglas H. Weitzel, Michael Cohen-Wolkowiez
Publikováno v:
Journal of Nuclear Medicine. 56:1793-1799
Intraarterial microdosing (IAM) is a novel drug development approach combining intraarterial drug delivery and microdosing. We aimed to demonstrate that IAM leads to target exposure similar to that of systemic full-dose administration but with minima